Navigation LinksBiology NewsHealth NewsBiology TechnologyMedicine Technology


We're sorry, that page (http://www.bio-medicine.org/biology-technology-1/oncogenex-reports-third-quarter-2009-financial-results-14740-3/;msg90356) was not found.

Search biology technology 1 oncogenex reports third quarter 2009 financial results 14740 3 ;msg90356 at Google

Search biology technology 1 oncogenex reports third quarter 2009 financial results 14740 3 ;msg90356 at Yahoo

Search biology technology 1 oncogenex reports third quarter 2009 financial results 14740 3 ;msg90356 at Msn

Google
 
(Date:11/22/2009)...s Pharmaceuticals today announced that its scienti... mutated IDH1 gene has a novel enzyme activity con...his breakthrough discovery shows that the mutated ...rate (2HG), which may contribute to the formation ...mon type of brain cancers. This discovery appears ...
(Date:11/20/2009)...vember 2009 issue of the journal GENETICS ( http...y of genes (1-aminocyclopropane-1-carboxylate synt... of ethylene. This gas affects many aspects of pla...dation for future genetic manipulation that could ... thrive in difficult terrain, increase yields, and...
(Date:11/20/2009)...eir abstracts to the World Congress on Osteoporosi...ing devoted to all aspects of osteoporosis and ost...s will be held in Florence, Italy from May 5-8, 20...d online at http://www.iofwco-ecceo10.org , T...F and ESCEO are pleased to announce that seven spe...
Breaking Biology News(10 mins):Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 2Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 3Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 4It's a gas: New discovery may lead to heartier, high-yielding plants 2Special sessions announced for World Congress on Osteoporosis 2010 - IOF WCO - ECCEO10 2Special sessions announced for World Congress on Osteoporosis 2010 - IOF WCO - ECCEO10 3Recession Continues to Depress Sales at Allied Healthcare Products 6066 1Recession Continues to Depress Sales at Allied Healthcare Products 6066 2Recession Continues to Depress Sales at Allied Healthcare Products 6066 3Recession Continues to Depress Sales at Allied Healthcare Products 6066 4Recession Continues to Depress Sales at Allied Healthcare Products 6066 5Recession Continues to Depress Sales at Allied Healthcare Products 6066 6Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 6061 1Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 6061 2Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 6061 3Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 6061 4Physicians Losing Control of Medicine 3A New Survey Reports Medical Malpractice as Primary Reason 0A 60873 1Physicians Losing Control of Medicine 3A New Survey Reports Medical Malpractice as Primary Reason 0A 60873 2Physicians Losing Control of Medicine 3A New Survey Reports Medical Malpractice as Primary Reason 0A 60873 3Physicians Losing Control of Medicine 3A New Survey Reports Medical Malpractice as Primary Reason 0A 60873 4
(Date:11/23/2009)...dy points up weaknesses of drug approval process i...DAY, Nov. 23 (HealthDay News) -- Problems with the... risk for heart attack, stroke and death, were kno...l from the market in 2004, a new report says. ,...mp; Co., dangerous side effects were evident in 20...
(Date:11/23/2009)..., PartnershipswithMinorityBanksin Washington ...lif. and Columbia , S.C. IntendedtoSpurEconom.../PRNewswire-USNewswire/--DaVita,thenation,sleading...deMinorityBankInitiativedesignedtocreatejobsandspu...rywithinvestmentsinleadingcommunityandminority-own...
(Date:11/23/2009)..., DALLAS,Nov.23/PRNewswire/-- ,, WHAT: ,...mofTheBerylCompanies, thenation,sleadinghealthcar...toeffectivelyreachconsumersineverygenerationwithap...we,formerCEOofMinuteClinic,thisWebinarwillsuppleme...nerationalPerspective,"whichdiscusseshowconsumersw...
(Date:11/23/2009)..., SOUTHAMPTON,N.Y.,Nov.23/PRNewswire-USNewswire...hnPaulsonhavedonated$5milliontofundanewEmergencyDe...andwillenabletheHospitaltoalmostdoubletheexistings...sidentsandvisitorsoftheSouthForkofLongIsland. ,...PaulsonEmergencyDepartment willprovideacentralized...
(Date:11/23/2009)...OBOKEN, N.J. The Center for Science Writings at S...volution of God," a talk by Robert Wright, journal...mber 2, 2009, 4:00-5:30 p.m. at the Babbio Center ...free and open to the public and the media., In h...g journalist Robert Wright, renowned for his popul...
Breaking Medicine News(10 mins):Health News: Vioxx Problems Known Years Before Recall 2Health News: Vioxx Problems Known Years Before Recall 3Health News: Vioxx Problems Known Years Before Recall 4Health News:DaVita Launches Minority Bank Initiative with $5 Million Investment in Underserved Communities Across the Country 2Health News:DaVita Launches Minority Bank Initiative with $5 Million Investment in Underserved Communities Across the Country 3Health News:Tips to Improve Healthcare Customer Service Across All Generations 2Health News:Southampton Hospital Receives $5 Million Gift for New Emergency Department 2
Plant DNAzol Reagent from Invitrogen
Universal Amplification Primer from Invitrogen
BacVector-3000 Transfection Kit from Novagen
BD BaculoGoldTM Transfection Kit 5 transfections from BD Biosciences Pharmingen
Biology Products:
Apolipoprotein A-1
Apolipoprotein A-1 (Liquid)
Urea (BUN)
Gamma GT (Modified IFCC)
Medicine Products:
(Date:11/20/2009)..., , , , , , , ,... , AUDIO: , A team of scientists fro...ty of Arizona, Cold Spring Harbor Laboratory and I...NA of corn. The... , , Click here... , , , , , , , ...
(Date:11/20/2009)..., ROCKVILLE, Md., Nov. 20 /PRNewswire-FirstCall...d that it has priced an underwritten public offeri...ice to the public of $3.30 per share. The approxi...g the underwriting discounts and commissions, will...ls of our VLP-based vaccines, internal research an...
(Date:11/20/2009)... METTLER TOLEDO recently announce...webinar, “The Role of Process Analytical Tec...ring” on December 1, 2009. , ... The Role of Process Analytical Technology (PAT) i...n December 1, Process Analytical Technology (PAT) ...
(Date:11/19/2009)..., BLAUVELT, N.Y., Nov. 19 Dr. Mat... extract, responds to a press release issued on No...arian company for making false and self-serving st...ences. ,, Dr. Hidvegi stated from his office i...that research on Avemar does not apply to AveULTRA...
Breaking Biology Technology:Amaizing: Corn genome decoded 2Amaizing: Corn genome decoded 3Amaizing: Corn genome decoded 4Novavax Prices Public Offering of Common Stock 2Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2
(Date:11/23/2009).../-- CryoLife,Inc. (NYSE: CRY ),animplantablebiolog...company,announcedtodaythatitisscheduledtoparticipa...ferenceatTheNewYorkPalaceHotelonDecember1,2009. ,...icerofCryoLife,Inc.,willprovideacorporateoverviewr...ionandanswersessionat4:30p.m.EasternTime. ,, Cr...
(Date:11/23/2009)...irstCall/--WoundManagementTechnologies,Inc.,(OTCBu...ymedicalproducts,announcedthatithasfileditQ32009fi...ntbusinessupdatetoillustratethedevelopmentsduringt...5%to$102,926vs.Q32008salesof$77,084. , Shareh...2008shareholderequityof$(321,257) , Totalasse...
(Date:11/23/2009)...rstCall/--Pharmasset,Inc.(Nasdaq: VRUS )announcedt...e(SWX:ROG.VX;RO.S,OTCQX:RHHBY),willcontinueforther...btrialofRG7128,afirst-in-classnucleosideanalogpoly...irus(HCV)infection.Thedecisionwasreachedafterasche...DMC)ofallavailablesafetydatafromthefirstcohortofap...
Breaking Medicine Technology:CryoLife to Present at 21st Annual Piper Jaffray Health Care Conference 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 4Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 5Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 2Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 3Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 4Most Who Want Swine Flu Shot Cant Get It 60868 1Most Who Want Swine Flu Shot Cant Get It 60868 2Most Who Want Swine Flu Shot Cant Get It 60868 3Father Norman Weslin and Four Pro Lifers Still in Jail 60863 1Seven LWW Nursing Editors Recognized as Leaders by American Academy of Nursing 60858 1Seven LWW Nursing Editors Recognized as Leaders by American Academy of Nursing 60858 2Seven LWW Nursing Editors Recognized as Leaders by American Academy of Nursing 60858 3